This would consider how microneedles can allow at-home delivery of vaccines and medicines ordinarily requiring injection by a healthcare professional, thus taking pressure off over-burdened health systems on a long-term basis and talk about opportunities and challenges.
Ryan F. Donnelly, Chair in Pharmaceutical Technology , Queen's University Belfast
Twinkle Christian, Process Development Scientist, Drug Product Technologies Group, Amgen
David Hipkiss, Chief Executive Officer, Enesi Pharma
Sudhakar Garad, Global Head of Chemical and Pharmaceutical Profiling, Novartis Institutes for BioMedical Research
Anne Moore, Professor , University College Cork
Jeffrey T. Blue, Executive Director, Vaccine Drug Product Development PR&D, MSD